drugset / Trial / NCT03889379
Albuterol and Immune Cell Composition
NaSingle-groupOpen-labelBasic science
Summary
The aim of this pilot study is to determine the effects of albuterol on the composition of immune cells in the bloodstream for possible future use in patients with neuroblastoma.
Timeline
- Start
- 2019-01-20
- Primary completion
- 2021-06-20
- Completion
- 2021-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salbutamol | Unknown | 2.5 mg | Inhaled |
Indications
No indication recorded.